Parker Cassidy

Director at Nucleix

Parker Cassidy is a Partner at Sands Capital and focuses on the firm’s diagnostic investments. He has a BS in Mechanical Engineering from Boston University and an MBA from Darden Graduate School of Business Administration from the University of Virginia. Prior to Sands Capital, Parker was a Principal on the investment team at RA Capital Management. Parker also worked at Farcast Biosciences where he served as the Chief Commercial Officer and as the Head of Strategy and Business Development. Prior to Farcast Biosciences, Parker held various leadership roles of increasing responsibility at both Becton Dickinson and Serologicals.”


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Nucleix

Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.


Industries

Headquarters

Na'an, Israel

Employees

51-200

Links